A recent study suggests that people with poor vision sensitivity are more likely to go on and develop Alzheimer's disease, ...
Poets have written it for years, that our eyes are the windows to our souls but it turns out, they are a lot more than that.
Previous research has shown that the risk of developing dementia in the future can be predicted from cognitive functions such as vision and hearing. It has now been newly discovered that the ...
Nine months into the U.S. launch of the first drug proven to slow the advance of Alzheimer's, Eisai and Biogen's Leqembi is ...
A person's ability to navigate could help to predict Alzheimer's disease years before symptoms appear, new research suggests Doctors have issued a warning that a sign of Alzheimer's could manifest ...
Alzheimer's disease (AD) remains one of the most challenging and prevalent neurodegenerative disorders, affecting millions of individuals worldwide. In a new study published in Developmental Cell ...
A stroke in the eye occurs when blood flow to the retina is blocked. Treatment depends on the type of blockage and the severity of the damage. Early medical care improves outcomes. Blood vessels ...
Evaporative dry eye is a type of dry eye disease that occurs when your tears evaporate too quickly, leaving insufficient tears to keep your eyes lubricated. Evaporative dry eye (EDE) is the most ...
In this model of heritable Alzheimer's disease, mice usually begin developing plaques at nine to 10 months of age, and behavioral signs of cognitive decline begin to appear at 11 to 12 months of ...
At the beginning of March, the FDA delayed approval of another Alzheimer’s drug, an anti-amyloid called donanemab. Credit: Shutterstock In the past few years pharmaceutical companies have developed a ...
More than 6 million Americans have Alzheimer’s disease, the most common cause of dementia. There’s no cure, but Leqembi ...
The first drug shown to slow Alzheimer’s hit the U.S. market over a year ago, but sales have lagged and diagnosis and treatment remain complicated The first drug shown to slow Alzheimer’s ...